Related references
Note: Only part of the references are listed.Immunogenicity of varying dosages of 7-valent pneurnococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Lisa A. Jackson et al.
VACCINE (2007)
Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage
Rosalyn J. Singleton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae
MH Kyaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Streptococcus pneumoniae:: Epidemiology, risk factors, and clinical features
Å Örtqvist et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the Intermountain West:: Emergence of nonvaccine serogroups
CL Byington et al.
CLINICAL INFECTIOUS DISEASES (2005)
Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
LA Jackson et al.
VACCINE (2005)
Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae
BT Hu et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2005)
Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine
TR Talbot et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil
AP Brandao et al.
VACCINE (2004)
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
S Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(F)
SA Quataert et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2004)
Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia
J Törling et al.
VACCINE (2003)
Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein
KK Kamboj et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine
S Jonsson et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine
SB Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children
R Borrow et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998 -: Opportunities for prevention in the conjugate vaccine era
KA Robinson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults
FP Kroon et al.
VACCINE (2000)
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine
P Richmond et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
